BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8060310)

  • 1. Mutants of smooth muscle myosin light chain kinase at tryptophan 800.
    Matsushima S; Huang YP; Dudas CV; Guerriero V; Hartshorne DJ
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1329-36. PubMed ID: 8060310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan fluorescence quenching by methionine and selenomethionine residues of calmodulin: orientation of peptide and protein binding.
    Yuan T; Weljie AM; Vogel HJ
    Biochemistry; 1998 Mar; 37(9):3187-95. PubMed ID: 9485473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence of a tryptophan bearing peptide from smooth muscle myosin light chain kinase upon binding to two closely related calmodulins.
    Chabbert M; Piémont E; Prendergast FG; Lami H
    Arch Biochem Biophys; 1995 Oct; 322(2):429-36. PubMed ID: 7574718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the N-terminal region of the skeletal muscle myosin light chain kinase target sequence in its interaction with calmodulin.
    Findlay WA; Gradwell MJ; Bayley PM
    Protein Sci; 1995 Nov; 4(11):2375-82. PubMed ID: 8563635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
    Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
    Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of the inhibitory domain of smooth muscle myosin light chain kinase by site-directed mutagenesis.
    Ito M; Guerriero V; Chen XM; Hartshorne DJ
    Biochemistry; 1991 Apr; 30(14):3498-503. PubMed ID: 2012809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myosin light chain kinase as a multifunctional regulatory protein of smooth muscle contraction.
    Gao Y; Ye LH; Kishi H; Okagaki T; Samizo K; Nakamura A; Kohama K
    IUBMB Life; 2001 Jun; 51(6):337-44. PubMed ID: 11758800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an epitope-tagged calmodulin useful for the analysis of calmodulin-binding proteins: addition of a hemagglutinin epitope does not affect calmodulin-dependent activation of smooth muscle myosin light chain kinase.
    Szymanska G; O'Connor MB; O'Connor CM
    Anal Biochem; 1997 Oct; 252(1):96-105. PubMed ID: 9324946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin regulation of smooth-muscle myosin light-chain kinase.
    Means AR; George SE
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S25-9. PubMed ID: 2469874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomerization of smooth muscle myosin light chain kinase and its modifications by melittin and calmodulin.
    Babiychuk EB; Sobieszek A
    Biopolymers; 1997 Nov; 42(6):673-86. PubMed ID: 9358732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of basic residues involved in activation and calmodulin binding of rabbit smooth muscle myosin light chain kinase.
    Fitzsimons DP; Herring BP; Stull JT; Gallagher PJ
    J Biol Chem; 1992 Nov; 267(33):23903-9. PubMed ID: 1429728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of beta-sheet interactions in domain stability, folding, and target recognition reactions of calmodulin.
    Browne JP; Strom M; Martin SR; Bayley PM
    Biochemistry; 1997 Aug; 36(31):9550-61. PubMed ID: 9236001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutron-scattering studies reveal further details of the Ca2+/calmodulin-dependent activation mechanism of myosin light chain kinase.
    Krueger JK; Zhi G; Stull JT; Trewhella J
    Biochemistry; 1998 Oct; 37(40):13997-4004. PubMed ID: 9760234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of tryptophan residues in an integral membrane protein: diacylglycerol kinase.
    Clark EH; East JM; Lee AG
    Biochemistry; 2003 Sep; 42(37):11065-73. PubMed ID: 12974643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional consequences of truncating amino acid side chains located at a calmodulin-peptide interface.
    Chin D; Sloan DJ; Quiocho FA; Means AR
    J Biol Chem; 1997 Feb; 272(9):5510-3. PubMed ID: 9038155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the non-muscle myosin light chain kinase (MLCK) deletion constructs on CV1 fibroblast contractile activity and proliferation.
    Wadgaonkar R; Nurmukhambetova S; Zaiman AL; Garcia JG
    J Cell Biochem; 2003 Feb; 88(3):623-34. PubMed ID: 12532337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectroscopic characterization of a high-affinity calmodulin-target peptide hybrid molecule.
    Martin SR; Bayley PM; Brown SE; Porumb T; Zhang M; Ikura M
    Biochemistry; 1996 Mar; 35(11):3508-17. PubMed ID: 8639501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of myosin light chain kinase and nitric oxide synthase activities by engineered calmodulins with duplicated or exchanged EF hand pairs.
    Persechini A; Gansz KJ; Paresi RJ
    Biochemistry; 1996 Jan; 35(1):224-8. PubMed ID: 8555178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of calmodulin and smooth muscle myosin light chain kinase: application of a label selection technique with trace acetylated calmodulin.
    Jackson AE; Carraway KL; Payne ME; Means AR; Puett D; Brew K
    Proteins; 1987; 2(3):202-9. PubMed ID: 3128785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.